Survivorship: immunizations and prevention of infections, version 2.2014.

Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriguez MA, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA
J Natl Compr Canc Netw. 2014 12 (8): 1098-111

PMID: 25099442 · PMCID: PMC4465238 · DOI:10.6004/jnccn.2014.0107

Cancer survivors are at an elevated risk for infection because of immune suppression associated with prior cancer treatments, and they are at increased risk of complications from vaccine-preventable diseases. This section of the NCCN Guidelines for Survivorship provides recommendations for the prevention of infections in survivors through education, antimicrobial prophylaxis, and the judicious use of vaccines. These guidelines provide information about travel and gardening precautions and safe pet care/avoidance of zoonosis, and include detailed recommendations regarding vaccinations that should be considered and encouraged in cancer and transplant survivors.

Copyright © 2014 by the National Comprehensive Cancer Network.

MeSH Terms (9)

Communicable Diseases Guidelines as Topic Humans Immunization Neoplasms Risk Assessment Survival Rate Survivors Vaccination

Connections (1)

This publication is referenced by other Labnodes entities: